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Dear Editor,
We read with interest the paper by Toldo and co-workers
addressing the important issue of comorbidity between
epilepsy and headache/migraine [1]. In fact, although these
are both chronic disorders with episodic attacks and their
association has been long recognized, the common
molecular mechanisms remain so far elusive [2–4]. Indeed,
recent data suggest shared genetic substrates and pheno-
typic-genotypic correlations with mutations in some ion
transporters genes, including CACNA1A, ATP1A2, SCN1A
[3, 4]. In their latest study, Toldo et al. evaluated the dis-
tribution of ﬁve polymorphisms of SCN1A, the gene
encoding the a-subunit of the neuronal voltage-gated
sodium channel Nav1.1, in children and adolescents with
headache and epilepsy compared to controls. They con-
cluded that SCN1A is not involved in the pathogenesis of
comorbidity between headache/migraine and epilepsy [1].
Despite this negative study, neuronal hyperexcitability
and increased susceptibility to cortical spreading depres-
sion remain important molecular mechanisms in the path-
ophysiology of this association. In the coming decade it is
possible that International efforts to collect large well-
phenotyped samples and the current technical possibilities
of massive genotyping will shed light on the genetic
mechanisms involved in with headache/migraine and epi-
lepsy. On the other hand, the role of additional, non genetic
factors inﬂuencing the excitation threshold, e.g., mito-
chondrial dysfunction, disturbance in neurotransmitters
metabolism, or inﬂammatory factors-alone or in combina-
tion-can not be excluded a priori [3, 4]. Indeed, any of
these triggering factors, irrespective of their nature
(genetically determined or not), could potentially lead to a
paroxysmal and transient cortical excitability change
leading to prolonged neuronal depolarization (seizure) or
spreading depression (headache/migraine) [2, 3].
Among the potential practical implications arising from
these observations, there is the urgent need for a revision of
either International Classiﬁcations of Epilepsy and Head-
ache disorders [2, 3, 5]. Finally, insight into the molecular
mechanisms involved in the association between headache/
migraine and epilepsy is crucial to identify drug targets for
improving patients’ treatment.
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